How do I buy Lineage Cell Therapeutics (LCTX) stock?

You can purchase shares of Lineage Cell Therapeutics (AMEX:LCTX) through any online brokerage.View our list of the best stock brokerages

Who are Lineage Cell Therapeutics (LCTX) competitors?

Other companies in Lineage Cell Therapeutics’s space includes: Tectonic Therapeutic Inc (NASDAQ:TECX), 4D Molecular Therapeutics Inc (NASDAQ:FDMT), Burning Rock Biotech Ltd (NASDAQ:BNR), PepGen Inc (NASDAQ:PEPG) and ADC Therapeutics SA (NYSE:ADCT).

What is the forecast, or price target, for Lineage Cell Therapeutics (LCTX) stock?

Lineage Cell Therapeutics has a consensus price target of $4.86.

What is the current price for Lineage Cell Therapeutics (LCTX)?

The stock price for Lineage Cell Therapeutics (AMEX: LCTX) is $1.72 last updated January 16, 2026 at 6:58 PM EST.

Does Lineage Cell Therapeutics (LCTX) pay a dividend?

There are no upcoming dividends for Lineage Cell Therapeutics.

When is Lineage Cell Therapeutics (AMEX:LCTX) reporting earnings?

Lineage Cell Therapeutics does not have any upcoming earnings scheduled.

Is Lineage Cell Therapeutics (LCTX) going to split?

There is no upcoming split for Lineage Cell Therapeutics.

What sector and industry does Lineage Cell Therapeutics (LCTX) operate in?

Lineage Cell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

Lineage Cell Therapeutics (LCTX) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies inclu...

Comments